Skip to content

The Effect of the Behavioral intervention based on Acceptance on Pregnancy Related Anxiety and Salivary level of Interleukin-6 in Pregnant Women

The Effect of the Behavioral intervention based on Acceptance on Pregnancy Related Anxiety and Salivary level of Interleukin-6 in Pregnant Women

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250716066519N1
Enrollment
110
Registered
2025-08-02
Start date
2025-07-22
Completion date
Unknown
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy-related anxiety. Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

Interventions

Intervention 1: Intervention group: Acceptance-based behavioral intervention as an 8-week program, held for groups with a maximum of 10 participants, for 90 minutes each week. Intervention 2: Control

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Mothers aged 18 years or older Singleton pregnancy Normal maternal Body Mass Index (BMI) Gestational age between 15-22 weeks Ability to attend all educational sessions Ability to read and write in Persian Iranian ethnicity Full consciousness and acceptable auditory and speech capabilities for receiving education and responding to questions

Exclusion criteria

Exclusion criteria: History of or current diagnosis of diabetes History of any meditation or mindfulness practices History of treatment with anti-convulsant, anti-depressant, or anti-anxiety medications History of smoking, alcohol, drug, or psychotropic substance use History of or current medical conditions History of or current diagnosis of serious psychiatric disorders, including psychotic disorders, bipolar disorder, and depression requiring treatment History of or current diagnosis of hypertension History of or current diagnosis of dental diseases

Design outcomes

Primary

MeasureTime frame
Pregnancy Anxiety Questionnaire score. Timepoint: Determine the Pregnancy Anxiety Questionnaire score at the beginning of the study (before the start of the intervention) and immediately after the end of the intervention (8 weeks later). Method of measurement: Vandenbergh Pregnancy Anxiety Questionnaire.;Salivary interleukin-6 level. Timepoint: Measuring interleukin-6 levels at the beginning of the study (before the start of the intervention) and immediately after the end of the intervention (8 weeks later). Method of measurement: Salivary Interleukin-6 ELISA kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNahid Akbari

Iran University of Medical Sciences

akbari1420@gmail.com+98 21 8888 2886

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026